Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Study at the University Hospital of Bern

NCT04444856 · clinicaltrials.gov ↗

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Postpartum Haemorrhage

Interventions

DRUG: Eptacog alfa (activated)
OTHER: Standard of care

Sponsor

Novo Nordisk A/S